Profile Related Evidence to Determine Individualized Cancer Therapy (PREDICT) Program in Advanced Cancer Patients

Status unconfirmed

Conditions studied: Advanced Cancers

In brief

The goal of this laboratory research study is to collect and analyze treatment, molecular profiling and biomarker data. The results of the data analysis will be used to better understand how to characterize tumors and identify therapies that may be tailored to individual patients and to identify and/or predict side effects that may occur and/or predict which therapies may be best for participants. Research may also be done on your existing tissue to identify new biomarkers.

Key facts

Study ID

NCT02160366

Run by

M.D. Anderson Cancer Center

People needed

2000

Starts

2010-09-27

Expected to finish

2020-09-27

Last updated by the study team

2020-01-10

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• All patients referred to the Clinical Center for Targeted Therapy are potentially eligible for recruitment.

You may not qualify if…

• n/a

Where it is running

• University of Texas MD Anderson Cancer Center — Houston, Texas, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.